AstraZeneca Statistics and Revenue Totals (2023)
Last Updated on: June 6th, 2023
Here are a few of the most interesting AstraZeneca statistics I was able to dig up including AstraZeneca revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
AstraZeneca Facts
- Website: Official Website
- Year Founded: 1913
- Headquarters: Cambridge, England
- Current Chief Executive: Pascal Soriot
- Subsidiaries / Brands: Sybicort, Tagrisso, Nexium, Crestor, Farxiga, Brilinta, Pulmicort, Faslodex and Zoladex
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries, and its innovative medicines are used by millions of patients worldwide. (source)
AstraZeneca Statistics
AstraZeneca Revenue Totals
AstraZeneca annual revenue:
- 2022: $44.35 billion
- 2021: $36.5 billion
- 2020: $25.89 billion
- 2019: $24.384 billion
- 2018: $22.1 billion
- 2017: $22.5 billion
- 2016: $23 billion
- 2015: $24.7 billion
Additional AstraZeneca Statistics
AstraZeneca largest therapeutic area (based on sales):
Cardiovascular & Metabolic Diseases (36%)
AstraZeneca largest geographical region (based on sales):
Please note that some of these numbers are easier to find than others. A few of these AstraZeneca statistics come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.
Related Categories:
Related Tags:
